Segment Information (Details) (USD $)	3 Months Ended				6 Months Ended
	Dec. 28, 2013		Dec. 29, 2012		Dec. 28, 2013		Dec. 29, 2012
Segment Reporting Information [Line Items]
Net sales	$ 979,000,000	[1]	$ 883,000,000	[1]	$ 1,912,400,000	[1]	$ 1,652,700,000	[1]
Operating Income (Loss)	86,600,000	[1]	163,900,000	[1]	266,200,000	[1]	320,400,000	[1]
Intangible assets amortization expense	43,800,000	[1]	21,600,000	[1]	73,600,000	[1]	40,300,000	[1]
Assets From Continuing Operations	13,712,800,000	[1]	4,294,400,000	[1]	13,712,800,000	[1]	4,294,400,000	[1]
Consumer Healthcare [Member]
Segment Reporting Information [Line Items]
Net sales	536,300,000		539,300,000		1,074,800,000		989,700,000
Operating Income (Loss)	89,500,000		86,100,000		179,500,000		165,400,000
Intangible assets amortization expense	5,300,000		4,900,000		10,600,000		7,100,000
Assets From Continuing Operations	2,345,500,000		1,771,500,000		2,345,500,000		1,771,500,000
Nutritionals [Member]
Segment Reporting Information [Line Items]
Net sales	139,700,000		121,900,000		268,700,000		225,300,000
Operating Income (Loss)	13,300,000		7,200,000		21,000,000		11,000,000
Intangible assets amortization expense	7,400,000		7,300,000		14,700,000		14,600,000
Assets From Continuing Operations	1,014,000,000		960,700,000		1,014,000,000		960,700,000
Rx Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Net sales	246,600,000		162,500,000		450,200,000		325,500,000
Operating Income (Loss)	100,400,000		64,100,000		183,500,000		132,600,000
Intangible assets amortization expense	21,500,000		8,500,000		37,700,000		16,900,000
Assets From Continuing Operations	1,940,100,000		1,184,900,000		1,940,100,000		1,184,900,000
API [Member]
Segment Reporting Information [Line Items]
Net sales	30,000,000		40,900,000		73,200,000		77,300,000
Operating Income (Loss)	8,200,000		13,800,000		30,600,000		27,100,000
Intangible assets amortization expense	500,000		500,000		1,000,000		900,000
Assets From Continuing Operations	284,700,000		275,400,000		284,700,000		275,400,000
Specialty Sciences [Member]
Segment Reporting Information [Line Items]
Net sales	7,400,000		0		7,400,000		0
Operating Income (Loss)	(19,000,000)		0		(19,000,000)		0
Intangible assets amortization expense	8,700,000		0		8,700,000		0
Assets From Continuing Operations	8,023,800,000		0		8,023,800,000		0
Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales	19,000,000		18,400,000		38,100,000		34,900,000
Operating Income (Loss)	600,000		700,000		1,800,000		1,100,000
Intangible assets amortization expense	400,000		400,000		900,000		800,000
Assets From Continuing Operations	104,700,000		101,900,000		104,700,000		101,900,000
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Net sales	0		0		0		0
Operating Income (Loss)	(106,400,000)		(8,000,000)		(131,200,000)		(16,800,000)
Intangible assets amortization expense	0		0		0		0
Assets From Continuing Operations	$ 0		$ 0		$ 0		$ 0

[1] {F|ahBzfndlYmZpbGluZ3MtaHJkcmoLEgZYTUxEb2MiXlhCUkxEb2NHZW5JbmZvOjk5YTAwYzNkYmVjMTQxMTc4MWMyY2U1MWJmNmQ2MzI4fFRleHRTZWxlY3Rpb246QUU2MEJEQzJDRTEzRTZDQjE0OTM1N0VGREY4QTAxNTcM}